Thanks to the development of molecular biology and genetic engineering in the 80s of last century, assortment of drugs has included a new generation of medicinal products, containing the active substance (proteins or glycoproteins) derived by Recombinant DNA Technology. The guidelines and requirements for the production and control of recombinant proteins set out.